Vaxart Inc

-0.33 (-4.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)748.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.9 Million
Adjusted EPS-$0.08
See more estimates
10-Day MA$7.56
50-Day MA$8.05
200-Day MA$7.07
See more pivots

Vaxart, Inc. Stock, NASDAQ:VXRT

385 Oyster Point Boulevard, Suite 9A, South San Francisco, California 94080
United States of America
Phone: +1.650.550.3500
Number of Employees: 14


Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.